The Safety and Efficacy of a Therapeutic Vaccine for Chronic Hepatitis B: A Follow-Up Study of Phase III Clinical Trial

被引:14
|
作者
Akbar, Sheikh Mohammad Fazle [1 ]
Al Mahtab, Mamun [2 ]
Aguilar, Julio Cesar [3 ]
Yoshida, Osamu [1 ]
Khan, Sakirul [4 ]
Penton, Eduardo [3 ]
Gerardo, Guillen Nieto [3 ]
Hiasa, Yoichi [1 ]
机构
[1] Ehime Univ, Grad Sch Med, Dept Gastroenterol & Metabol, Toon 7910295, Japan
[2] Bangabandhu Sheikh Mujib Med Univ BSMMU, Dept Hepatol, Dhaka 1000, Bangladesh
[3] Ctr Genet Engn & Biotechnol, Havana 10600, Cuba
[4] Oita Univ, Fac Med, Dept Microbiol, Oita 8795593, Japan
关键词
chronic hepatitis B; therapeutic vaccine; HBsAg; HBcAg vaccine; NASVAC; nasal vaccine; follow-up; CORE ANTIGEN; SURFACE; CANDIDATE; CELLS; HBCAG;
D O I
10.3390/vaccines10010045
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The objective of the present study was to assess the safety and efficacy of a therapeutic vaccine containing both HBsAg and HBcAg (NASVAC) in patients with chronic hepatitis B (CHB) three years after the end of treatment (EOT) as a follow-up of a phase III clinical trial. NASVAC was administered ten times by the nasal route and five times by subcutaneous injection. A total of 59 patients with CHB were enrolled. Adverse events were not seen in any of the patients. Out of the 59 CHB patients, 54 patients exhibited a reduction in HBV DNA, compared with their basal levels. Although all the patients had alanine transaminase (ALT) above the upper limit of normal (>42 IU/L) before the commencement of therapy, the levels of ALT were within the ULN level in 42 patients. No patient developed cirrhosis of the liver. The present study, showing the safety and efficacy of NASVAC 3 years after the EOT, is the first to report follow-up data of an immune therapeutic agent against CHB. NASVAC represents a unique drug against CHB that is safe, of finite duration, can be administered by the nasal route, is capable of reducing HBV DNA and normalizing ALT, and contains hepatic fibrosis.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Younger age and language barriers are associated with nonadherence to clinical follow-up in hepatitis B treatment
    Chi, H.
    Japhary, A.
    de Man, R. A.
    de Knegt, R. J.
    Janssen, H. L. A.
    Hansen, B. E.
    JOURNAL OF VIRAL HEPATITIS, 2018, 25 (10) : 1216 - 1219
  • [22] Long-term efficacy of plasma-derived hepatitis B vaccine among Chinese children: a 12-year follow-up study
    Liao, SS
    Li, RC
    Li, H
    Yang, JY
    Zeng, XJ
    Gong, J
    Wang, SS
    Li, YP
    Zhang, KL
    WORLD JOURNAL OF GASTROENTEROLOGY, 1999, 5 (02) : 165 - 166
  • [23] Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study
    Fung, James
    Seto, Wai-kay
    Wong, Danny Ka-ho
    Lai, Ching-lung
    Yuen, Man-fung
    LIVER INTERNATIONAL, 2015, 35 (03) : 854 - 859
  • [24] Long-term efficacy of plasma-derived hepatitis B vaccine: a 15-year follow-up study among Chinese children
    Liao, SS
    Li, RC
    Li, H
    Yang, JY
    Zeng, XJ
    Gong, J
    Wang, SS
    Li, YP
    Zhang, KL
    VACCINE, 1999, 17 (20-21) : 2661 - 2666
  • [25] Chronic hepatitis B in children with or without malignancies: A 13-year follow-up
    Usta, Merve
    Urganci, Nafiye
    Yildirmak, Zeynep Yildiz
    Vural, Sema Dogan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (07) : 2073 - 2079
  • [26] Chronic hepatitis B in children with or without malignancies:A 13-year follow-up
    Merve Usta
    Nafiye Urganc?
    Zeynep Y?ld?z Y?ldlrmak
    Sema Dogan Vural
    World Journal of Gastroenterology, 2015, (07) : 2073 - 2079
  • [27] Long term follow-up of children with chronic hepatitis B: a single center experience
    Bajin, Inci Yaman
    Demir, Hulya
    Temizel, Inci Nur Saltik
    Ozen, Hasan
    Yuce, Aysel
    TURKISH JOURNAL OF PEDIATRICS, 2019, 61 (06) : 846 - 851
  • [28] The Long Term Follow-up Results of Chronic Hepatitis B Cases: Cerrahpasa Experience
    Aslan, Ferhat
    Tabak, Omurr
    Ozaras, Resat
    Mert, Ali
    Tabak, Fehmi
    Senturk, Hakan
    VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL, 2011, 17 (01): : 32 - 35
  • [29] Predictors of Functional Cure of Chronic Hepatitis B Virus Infection: A Long-Term Follow-Up Study
    Wu, Jia-Feng
    Tai, Chi-San
    Chang, Kai-Chi
    Chen, Yuh-Jue
    Hsu, Chien-Ting
    Chen, Huey-Ling
    Ni, Yen-Hsuan
    Chang, Mei-Hwei
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2025, 23 (04) : 583 - 590.e3
  • [30] Follow-up Schedule for Patients With Sentinel Node-negative Cutaneous Melanoma (The MELFO Study) An International Phase III Randomized Clinical Trial
    Moncrieff, Marc D.
    Bastiaannet, Esther
    Underwood, Beverly
    Francken, Anne Brecht
    Garioch, Jennifer
    Damude, Samantha
    Heaton, Martin
    Deckers, Eric A.
    Patel, Nakul
    Hoekstra-Weebers, Josette E.
    Hoekstra, Harald J.
    ANNALS OF SURGERY, 2022, 276 (04) : E208 - E216